Dysregulated ΔNp63α Inhibits Expression of Ink4a/arf, Blocks Senescence, and Promotes Malignant Conversion of Keratinocytes

• Linan Ha,

  Affiliation Division of Monoclonal Antibodies, Center for Drug Evaluation and Research/Food and Drug Administration (CDER/FDA), Bethesda, Maryland, United States of America

  ⨯
• Roshini M. Ponnamperuma,

  Affiliation Division of Monoclonal Antibodies, Center for Drug Evaluation and Research/Food and Drug Administration (CDER/FDA), Bethesda, Maryland, United States of America

  ⨯
• Steven Jay,

  Affiliation SAIC-Frederick, Inc., Frederick, Maryland, United States of America

  ⨯
• M. Stacey Ricci,

  Current address: Division of Biological Oncology Products, Center for Drug Evaluation and Research/Food and Drug Administration (CDER/FDA), Silver Spring, Maryland, United States of America

  Affiliation Division of Monoclonal Antibodies, Center for Drug Evaluation and Research/Food and Drug Administration (CDER/FDA), Bethesda, Maryland, United States of America

  ⨯
• Wendy C. Weinberg

  * E-mail: wendy.weinberg@fda.hhs.gov

  Affiliation Division of Monoclonal Antibodies, Center for Drug Evaluation and Research/Food and Drug Administration (CDER/FDA), Bethesda, Maryland, United States of America

  ⨯